Choose your country

Seegene Receives Health Canada Approval for its COVID-19 Assay

SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- Seegene, Inc. announced that Health Canada (HC) authorized an interim order which allows the import and sale in Canada of Seegene's Allplex™ 2019-nCo...

How One Firm's Covid-19 Tests Help Control The Virus In South Korea

South Korea's coronavirus test makers in high demand

RAI, the national public broadcasting company of Italy, focused on the COVID-19 test kit of Seegene in an interview with the president of Arrow Diagnostics S.r.l (Seegene's subsidiary in Italy)

S. Korea to facilitate exports of COVID-19 diagnostic reagents: Moon

Virus Test-Kit Maker Meets Demand That Lifts Founder’s Fortune

CNN spotlighted “How this south Korean company created coronavirus test kits in three weeks"

Virus Testing Blitz Appears to Keep Korea Death Rate Low

Introducing Seegene COVID-19 assay on BFM TV in France : La high-tech française, arme anti-coronavirus

Seegene launches KFDA Approved COVID-19 Assay

SEOUL, Korea, Feb 18, 2020 – Korea Centers for Disease Control & Prevention notified Seegene Inc. (096530.KQ) that Korea Ministry of Food and Drug Safety (MFDS; Former KFDA) approved its novel coronav...

Seegene Highlights Clinical Automated Nucleic Acid Extraction System at ASM Microbe 2019

2019 American Society for Microbiology Microbe Conference: Booth #1062 SEOUL, Korea, June 21, 2019 ? Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered in So...

Seegene Establishes Brazilian Subsidiary Seegene Brazil Diagnostics LTDA to target IVD market in Latin America

SEOUL, Korea, June 18, 2019 ? Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies headquartered in South Korea, announced today the formation of a new subsidiary, Seegene do Br...

Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method

SEOUL, Korea, Nov 26, 2018 ? Seegene Inc. (096530.KQ), a leading developer of multiplex PCR assays, announced that multi-site clinical trials for measuring clinical performance on screening the dru...

Seegene Unveils New Real-time PCR Analysis Technology, Drastically Increasing Its Multiplexing Capacity

SEOUL, Korea, Sept 19, 2018 ? Seegene Inc. (096530.KQ), a leading developer of multiplex PCR technologies, today announced its proprietary technology, “MuCT™”. This is a real-time PCR based data ac...